Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COHERENT CORP. Board/Management Information 2010

May 18, 2010

30355_rns_2010-05-18_16fefb05-0588-4329-8d66-ee3389aca37c.zip

Board/Management Information

Open in viewer

Opens in your device viewer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) May 15, 2010

II-VI Incorporated

(Exact Name of Registrant as Specified in Its Charter)

Pennsylvania

(State or Other Jurisdiction of Incorporation)

0-16195 25-1214948
(Commission File Number) (IRS Employer Identification No.)
375 Saxonburg Boulevard, Saxonburg, Pennsylvania 16056
(Address of Principal Executive Offices) (Zip Code)

(724) 352-4455

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On May 15, 2010, Carl J. Johnson, Chairman (an Executive Officer position) of II-VI Incorporated (the “Company”), informed the Company that he will retire from his day-to-day responsibilities effective as of May 31, 2010. Dr. Johnson will continue in his role as Chairman of the Company’s Board of Directors where his primary focus will be on the strategic direction and corporate governance of the Company and the oversight of certain of the Company’s subsidiary operations.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

II-VI INCORPORATED
(Registrant)
Date: May 18, 2010 By: / S / F RANCIS J.
K RAMER
Francis J. Kramer
President and Chief Executive Officer
Date: May 18, 2010 By: / S / C RAIG A.
C REATURO
Craig A. Creaturo
Chief Financial Officer and Treasurer

2